Johnson & Johnson buy SVB Leerink LLC
Start price
23.01.25
/
50%
€141.20
Target price
23.01.26
€162.54
Performance (%)
23.72%
Price
18:29
€173.50
Summary
This prediction is currently active. The BUY prediction by SVB_Leerink_LLC currently has a performance of 23.72%. A total of €1.19 was paid as dividends for this prediction. This prediction currently runs until 23.01.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Johnson & Johnson | -2.124% | -2.124% |
| iShares Core DAX® | 1.917% | 1.088% |
| iShares Nasdaq 100 | 0.911% | 1.674% |
| iShares Nikkei 225® | 0.833% | -1.712% |
| iShares S&P 500 | 0.242% | 1.258% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Johnson & Johnson diskutieren
Johnson & Johnson (NYSE: JNJ) had its price target lowered by analysts at Leerink Partners from $182.00 to $169.00. They now have an "outperform" rating on the stock.
Ratings data for JNJ provided by MarketBeat